SAGE Open Medical Case Reports (Feb 2020)

Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging

  • Norihiro Kobayashi,
  • Keisuke Hirano,
  • Masahiro Yamawaki,
  • Motoharu Araki,
  • Tsuyoshi Sakai,
  • Yasunari Sakamoto,
  • Shinsuke Mori,
  • Masakazu Tsutsumi,
  • Masahiro Nauchi,
  • Naohiko Sahara,
  • Yohsuke Honda,
  • Kenji Makino,
  • Shigemitsu Shirai,
  • Masafumi Mizusawa,
  • Yuta Sugizaki,
  • Takahide Nakano,
  • Tomoya Fukagawa,
  • Toshihiko Kishida,
  • Yuki Kozai,
  • Yusuke Setonaga,
  • Shutaro Goda,
  • Yoshiaki Ito

DOI
https://doi.org/10.1177/2050313X20907825
Journal volume & issue
Vol. 8

Abstract

Read online

A 63 year-old woman with claudication underwent endovascular therapy for diffuse stenosis of the right superficial femoral artery in our hospital. We performed paclitaxel-coated balloon angioplasty using the IN.PACT™ Admiral™ and achieved acceptable results. After 42 days, we performed follow-up optical frequency domain imaging for the right superficial femoral artery lesion treated with paclitaxel-coated balloon and observed several high-intensity regions with attenuation on the lumen surface. Sustained drug availability is a notable characteristic of paclitaxel-coated balloon. To the best of our knowledge, this is the first report on the visualization of sustained drug retention on the lumen surface using follow-up optical frequency domain imaging after paclitaxel-coated balloon angioplasty in a human patient with superficial femoral artery disease.